ATP6V0A1 and obesity due to melanocortin 4 receptor deficiency: Thus, ATP6v0a1 is a target for future anti-obesity therapeutic strategies and the peripheral origin of this approach may reduce the likelihood of interfering with mental health than anti-obesity strategies that act directly on the brain.